FAQ

10-valent pneumococcal conjugate vaccine

Known as: PCV10, Pneumococcal 10-valent Conjugate Vaccine, ten-valent PCV 
An active immunizing vaccine used to prevent infection by the bacterium Streptococcus pneumoniae. It is indicated for disease caused by serotypes 1… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

1999-2017
0204019992017

Related topics

Related topics

3 relations
Pediatric TerminologyPneumococcal Conjugate Vaccine

Broader (1)

Pneumococcal vaccine

Related mentions per year

Related mentions per year

1949-2018
19401960198020002020
10-valent pneumococcal conjugate vaccine
Pneumococcal vaccine
Pneumococcal Conjugate Vaccine
Pediatric Terminology

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Early impact of 10-valent pneumococcal conjugate vaccine in childhood pneumonia hospitalizations using primary data from an active population-based surveillance.
BACKGROUND In Brazil, 10-valent pneumococcal conjugate vaccine (PCV10) was introduced in 2010 in the childhood routine… (More)
Is this relevant?
2015
2015
Invasive Pneumococcal Disease 3 Years after Introduction of 10-Valent Pneumococcal Conjugate Vaccine, the Netherlands
Three years after a 7-valent pneumococcal conjugate vaccine was replaced by a 10-valent pneumococcal conjugate vaccine in the… (More)
  • figure 1
  • figure 2
  • table 1
  • table 2
Is this relevant?
2015
2015
Impact of 10-valent pneumococcal conjugate vaccine on pneumococcal meningitis in children up to two years of age in Brazil.
The objective of this study was to analyze the impact of vaccination against Streptococcus pneumoniae on the morbidity and… (More)
Is this relevant?
2015
2015
Indirect cohort analysis of 10-valent pneumococcal conjugate vaccine effectiveness against vaccine-type and vaccine-related invasive pneumococcal disease.
We applied the indirect cohort method to estimate effectiveness of 10-valent pneumococcal conjugate vaccine (PCV10) among young… (More)
Is this relevant?
2014
2014
Population effect of 10-valent pneumococcal conjugate vaccine on nasopharyngeal carriage of Streptococcus pneumoniae and non-typeable Haemophilus influenzae in Kilifi, Kenya: findings from cross…
BACKGROUND The effect of 7-valent pneumococcal conjugate vaccine (PCV) in developed countries was enhanced by indirect protection… (More)
Is this relevant?
2014
2014
Susceptibility profiles and correlation with pneumococcal serotypes soon after implementation of the 10-valent pneumococcal conjugate vaccine in Brazil.
OBJECTIVES To evaluate the susceptibility patterns among Streptococcus pneumoniae recovered during the years 2010-2012 and to… (More)
Is this relevant?
2013
2013
A cost-effectiveness analysis of a 10-valent pneumococcal conjugate vaccine in children in six Latin American countries
BACKGROUND A recently developed 10-valent pneumococcal non-typeable H influenzae protein D-conjugate vaccine (PHiD-CV) is… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
2013
2013
Effect of 10-Valent Pneumococcal Vaccine on Pneumonia among Children, Brazil
Pneumonia is most problematic for children in developing countries. In 2010, Brazil introduced a 10-valent pneumococcal conjugate… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?
2012
2012
Cost-effectiveness of 2 + 1 dosing of 13-valent and 10-valent pneumococcal conjugate vaccines in Canada
BACKGROUND Thirteen-valent pneumococcal conjugate vaccine (PCV13) and 10-valent pneumococcal conjugate vaccine (PCV10) are two… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2011
2011
Immunization of preterm infants with 10-valent pneumococcal conjugate vaccine.
OBJECTIVE The safety and immunogenicity of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate… (More)
  • figure 1
  • table 1
  • table 4
  • figure 2
Is this relevant?